Tue 21 Apr 2015 13:12 AAP – 2 hours 29 minutes ago
https://au.finance.yahoo.com/news/novogen-poised-capital-raising-003707394.html
Cancer therapy biotech Novogen has placed its shares in a trading halt ahead of an expected announcement about a capital raising.
Novogen says it is preparing an announcement about a placement of ordinary shares and attaching options, along with an offer of ordinary shares.
It expects the halt to remain in place until Thursday at the latest.
Meanwhile, the biotech also says animal trials of its experimental anti-cancer drug Cantrixil have shown that it can prevent ovarian cancer tumours from returning in mice.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM